Skip to main content
TipRanks
Go Ultimate75% OFF

Jonathan Silverstein Insider Profile

4 Followers

Jonathan Silverstein, Director, Ten Percent Owner at Arcutis Biotherapeutics, holds 902.29K shares in Arcutis Biotherapeutics (Ticker: ARQT), holds 0.00 shares in Avedro (Ticker: ~AVDR), holds 0.00 shares in Glaukos (Ticker: GKOS). Most recently, Jonathan Silverstein Bought ― shares of Arcutis Biotherapeutics on Oct 06, 2020 for an estimated value of $12.40M.

Jonathan Silverstein's Trading History

ARQT
Arcutis Biotherapeutics
Oct 06, 2020Director, Ten Percent OwnerInformative Buy12.40M$25.50M
~AVDR
Avedro
Nov 25, 2019―Uninformative Sell―$0.00
GKOS
Glaukos
Mar 06, 2018DirectorInformative Sell26.79M$0.00
ACET
Adicet Bio
Jan 30, 2018DirectorUninformative Buy―$13.43M
SCPH
scPharmaceuticals
Nov 21, 2017―Uninformative Buy―$14.61M
ICPT
Intercept Pharma
Nov 27, 2015―Uninformative Buy―$21.31M
ROKA
Sorrento Tech Inc
Jul 24, 2014―Uninformative Buy―$19.75K
RLYP
Relypsa Inc
Nov 20, 2013―Uninformative Sell300.10K$318.03M
AVNR
Avanir Pharmaceuticals
――――
PODD
Insulet
―Director―$239.22M
NXTM
NxStage Medical
―――$166.67M

You May Also Like

Jonathan Silverstein insider profile FAQ

What is the percentage of profitable transactions made by Jonathan Silverstein?
The percentage of profitable transactions made by Jonathan Silverstein is 41%.
What is the average return per transaction made by Jonathan Silverstein?
The average return per transaction made by Jonathan Silverstein is -8.50%.
What stocks does Jonathan Silverstein hold?
Jonathan Silverstein holds: ARQT, ICPT, GKOS, SCPH, ACET, ~AVDR, ROKA, RLYP, NXTM, PODD, AVNR stocks.
What was Jonathan Silverstein’s latest transaction?
Jonathan Silverstein’s latest transaction was an Informative Buy of $12.40M.
What was Jonathan Silverstein's most profitable transaction?
Jonathan Silverstein’s most profitable transaction was an Informative Sell of ICPT stock on March 30, 2015. The return on the trade was 57.70%.
What is Jonathan Silverstein's role in Arcutis Biotherapeutics?
Jonathan Silverstein's role in Arcutis Biotherapeutics is Director, Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.